ConAgra Analysts Cut Their Forecasts After Q1 Results

ConAgra Brands Inc (NYSE: CAG) reported upbeat earnings for its first quarter on Thursday.

ConAgra Brands Inc (NYSE:CAG) reported upbeat earnings for its first quarter on Thursday.

The company posted quarterly sales of $2.90 billion, flat Y/Y, versus the consensus of $2.95 billion. Adjusted EPS increased 15.8% to $0.66, beating the consensus of $0.60.

ConAgra shares gained 1.6% to trade at $26.41 on Friday.

These analysts made changes to their price targets on ConAgra following earnings announcement.

  • Stifel cut the price target on ConAgra from $36 to $29. Stifel analyst Matthew Smith maintained a Hold rating.
  • RBC Capital lowered the price target on ConAgra from $36 to $32. RBC Capital analyst Nik Modi maintained a Sector Perform rating.
  • Jefferies slashed the price target on ConAgra from $30 to $28. Jefferies analyst Rob Dickerson maintained a Hold rating.

 

Check This Out: Top 4 Health Care Stocks That Are Preparing To Pump This Quarter

Total
0
Shares
Related Posts
Read More

Intellia Therapeutics Highlights Its 3-Year Strategic Priorities And Anticipated 2024 Key Milestones; Ended 2023 In A Strong Financial Position With Approximately $1B In Cash; Cash Runway Extended Into Mid-2026

Core priorities through 2026 include completion of Phase 3 study and BLA submission for NTLA-2002, completion of patient enrollment in the pivotal study of NTLA-2001, clinical validation of modular in vivo gene insertion

NTLA